Bamorovat Mehdi, Sharifi Iraj, Tahmouresi Amirhossein, Agha Kuchak Afshari Setareh, Rashedi Esmat
Leishmaniasis Research Center, Kerman University of Medical Sciences, Kerman, Iran.
Machine Learning and Modelling Expert, Kerman University of Medical Science, Kerman, Iran.
Transbound Emerg Dis. 2025 Jan 21;2025:5018632. doi: 10.1155/tbed/5018632. eCollection 2025.
Cutaneous leishmaniasis (CL) remains a significant global public health disease, with the critical distinction and exact detection between responsive and unresponsive cases dictating treatment strategies and patient outcomes. However, image-based methods for differentiating these groups are unexplored. This study addresses this gap by developing a deep learning (DL) model utilizing transfer learning to automatically identify responses in CL lesions. A dataset of 102 lesion images (51 per class; equally distributed across train, test, and validation sets) is employed. The DenseNet161, VGG16, and ResNet18 networks, pretrained on a massive image dataset, are fine-tuned for our specific task. The models achieved an accuracy of 76.47%, 73.53%, and 55.88% on the test data, respectively, with a sensitivity of 80%, 75%, and 100% and specificity of 73.68%, 72.22%, and 53.12%, individually. Transfer learning successfully addressed the limited sample size challenge, demonstrating the models' potential for real-world application. This work underscores the significance of automated response detection in CL, paving the way for treatment and improved patient outcomes. While acknowledging limitations like the sample size, the need for collaborative efforts is emphasized to expand datasets and further refine the model. This approach stands as a beacon of hope in the contest against CL, illuminating the path toward a future where data-driven diagnostics guide effective treatment and alleviate the suffering of countless patients. Moreover, the study could be a turning point in eliminating this important global public health and widespread disease.
皮肤利什曼病(CL)仍然是一种严重的全球公共卫生疾病,区分反应性和无反应性病例并进行准确检测对于确定治疗策略和患者预后至关重要。然而,尚未探索基于图像的方法来区分这些组别。本研究通过开发一种利用迁移学习的深度学习(DL)模型来自动识别CL病变的反应,填补了这一空白。使用了一个包含102张病变图像的数据集(每个类别51张;在训练集、测试集和验证集中平均分布)。在大规模图像数据集上预训练的DenseNet161、VGG16和ResNet18网络针对我们的特定任务进行了微调。这些模型在测试数据上的准确率分别为76.47%、73.53%和55.88%,灵敏度分别为80%、75%和100%,特异性分别为73.68%、72.22%和53.12%。迁移学习成功解决了样本量有限的挑战,证明了这些模型在实际应用中的潜力。这项工作强调了CL中自动反应检测的重要性,为治疗和改善患者预后铺平了道路。虽然认识到样本量等局限性,但强调需要共同努力来扩大数据集并进一步优化模型。在对抗CL的斗争中,这种方法是希望的灯塔,照亮了通往未来的道路,在未来,数据驱动的诊断将指导有效的治疗并减轻无数患者的痛苦。此外,该研究可能是消除这种重要的全球公共卫生和广泛传播疾病的一个转折点。
Comput Methods Programs Biomed. 2021-9
PeerJ Comput Sci. 2021-8-3
Biomed Eng Comput Biol. 2023-7-31
Int J Parasitol Drugs Drug Resist. 2023-4
IEEE J Biomed Health Inform. 2023-1
BMC Infect Dis. 2022-1-12